AMPRENAVIR

UNII:	5S0W860XNR
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₃₅N₃O₆S
Preferred Substance Name:	AMPRENAVIR
InChIKey:	YMARZQAQMVYCKC-OEMFJLHTSA-N
GSRS Full Record:	5S0W860XNR i

161814-49-9
(3S)-Tetrahydro-3-furyl [(αS)-α-[(1R-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate
(3S-(3R*(1R*,2S*)))-(3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL) TETRAHYDRO-3-FURANYL CARBAMATE
141W94
AGENERASE
AMPRENAVIR [EMA EPAR]
AMPRENAVIR [HSDB]
AMPRENAVIR [JAN]
AMPRENAVIR [MART.]
AMPRENAVIR [MI]
AMPRENAVIR [ORANGE BOOK]
AMPRENAVIR [USAN]
AMPRENAVIR [VANDF]
Amprenavir [WHO-DD]
J05AE05
KVX-478
VX-478
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
amprenavir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AMPRENAVIR

Synonyms and Mappings

Resources